Themis Medicare DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1.06×	−0.09×	0.88×	1.26×	0.97×
	−0.72×	1.22×	0.86×	0.88×	1.03×
	−15.8%	−2.9%	9.6%	10.3%	16.1%
	0.58×	0.58×	0.70×	0.71×	0.75×
	1.50×	1.50×	1.46×	1.50×	1.51×
	10.5%	0.3%	7.5%	12.1%	18.2%
	0.3%	0.3%	7.7%	12.1%	18.2%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

THEMISMED₹98.44

Themis Medicare Limited

· Pharma & Health

₹ CrorePeersLINCOLN BAJAJHCARE SIGACHI WANBURY AMRUTANJAN AHCLANUHPHRMcap ₹907 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.97	1.26	0.88	-0.09	1.06
Interest Burden (Pretax/EBIT) ×	1.03	0.88	0.86	1.22	-0.72
EBIT Margin %	16.07	10.28	9.65	-2.90	-15.76
Asset Turnover ×	0.75	0.71	0.70	0.58	0.58
Financial Leverage (Assets/Equity) ×	1.51	1.50	1.46	1.50	1.50
ROE (5-step product, year-end total equity) %	18.24	12.14	7.52	0.29	10.49
ROE (owners' profit / average owners' equity) %	18.15	12.14	7.65	0.29	0.29

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.